New Trial Tests Gabapentin As Treatment for Mucositis, Replacing Opioids
Reid W. Merryman, MD discusses results of a multicenter phase II trial
Jacqueline Garcia, MD discussed results from the Phase # VERONA study
Jennifer Brown, MD, PhD discusses results form the ALPINE trial
Austin Kim, MD discusses phase I/II study
Omar Nadeem, MD discusses results of the Phase II d-PRISM study
The Evolution of Cancer Predisposition Guidelines for Children
Updates in Breast Cancer Surgery
Physiatric Approach to Pain in Breast Cancer
Low-Dose Radiation Therapy for Arthritis
Modern Management of Borderline Resectable Pancreatic Cancer
Treatment Guideline: Inavolisib, Palbociclib, and Fulvestrant for Hormone Receptor-Positive/HER2-negative Metastatic Breast Cancer
Treatment Guideline: Ovarian Function Suppression and Estradiol Monitoring in Early-Stage Estrogen Receptor-Positive Breast Cancer
Tip Sheet: Adrenal Insufficiency in Breast Cancer Patients
AACR Pediatric Special Conference in Cancer Research
Is Subcutaneous Immunotherapy Ready for Prime Time? Join the June 23 webinar
Join Roswell Park Expert at 2nd Annual Upstate Cancer Symposium June 21
Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants
Dana-Farber Research Supports FDA Approval of T-DXd Plus Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer
Mobile Health Tool Helps Improve Quality of Life For Young Breast Cancer Survivors
Dana-Farber Study Highlights the Need for Faster, More Accurate Diagnosis of Rare Cancer
Triplet Therapy Shows Promise for BPDCN, a rare blood cancer, in Dana-Farber Study
Childhood leukemia care puts one in three families at risk of poverty
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
